Article Text

PDF
Gene therapy in head and neck cancer: a review
  1. E Chisholm*,1,
  2. U Bapat*,1,
  3. C Chisholm3,
  4. G Alusi2,
  5. G Vassaux1
  1. 1
    Molecular Oncology, Cancer Research UK, Barts and The London NHS Trust, London, UK
  2. 2
    Department ENT, Barts and The London NHS Trust, London, UK
  3. 3
    Department of Clinical Oncology, Charing Cross Hospital, Hammersmith, London, UK
  1. Dr E Chisholm, 44 Eastbury Grove, London W4 2JY, UK; edwardchisholm{at}doctors.org.uk

Abstract

Gene therapy for cancer is a rapidly evolving field with head and neck squamous cell cancer being one of the more frequently targeted cancer types. The number of clinical trials in the UK is growing and there is already a commercially available agent in China. Various gene therapy strategies along with delivery mechanisms for targeting head and neck cancer are reviewed.

  • head and neck
  • squamous cell
  • cancer
  • gene therapy
  • gene

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared

  • *Also Department ENT, Barts and The London NHS Trust, London, UK

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.